Printer Friendly

Shady Grove Fertility Simplifies Egg Donation, Donor Selection with New Portal.

M2 PHARMA-September 22, 2017-Shady Grove Fertility Simplifies Egg Donation, Donor Selection with New Portal


- US-based fertility center Shady Grove Fertility (SGF) has launched a new donor egg portal that simplifies and expedites the process of donating eggs for women ages 21 to 32, and selecting and reserving an egg donor for women who need donated eggs in order to conceive, the company said.

For egg donors, the new portal offers easier, faster pre-qualification in a mobile-friendly secure environment. Enhancements include a quick, online pre-application that sends immediate notification if they are prequalified to donate.

In addition, SGF has streamlined and simplified the prescreening process thereby reducing the amount of time to donate--meaning donors are often matched quickly with recipients. This is especially important for women who donate more than once, which comprises 65% of donors at SGF.

For women who need donor eggs to conceive, enhanced search features of prescreened, ready-to-donate donors and a new reservation system make finding a donor a simpler process.

The new portal offers many features that make sorting through the finest details of SGF's prescreened donors to match characteristics and find the right donor easier.

Recipients can also search through personal and family medical history, genetic disease history, educational background, and personal interests.

Essays are available to provide unique insight into the motivation and personality of each donor. Each donor provides childhood photos and many have consented to sharing their current adult photographs.

SGF's signature Shared Donor Egg Program offers cost savings, access to a larger pool of donors, and a significant reduction in wait time to select a donor.

The SGF portal now provides 24/7 updates regarding how many other donor matches are needed for match completion.

SGF is a fertility and IVF center of excellence with 41 physicians and 28 locations throughout MD, PA, VA, GA, and DC. The company offers patients individualized care, innovative financial options, and pregnancy rates among the highest of all national centers.

((Comments on this story may be sent to

COPYRIGHT 2017 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Sep 22, 2017
Previous Article:Synthego adds new member to advisory board.
Next Article:Innovus Partner Luminarie Receives New Zealand Approval for Zestra for Female Sexual Arousal Disorder as a Medical Device I.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters